Inferiority of Single‐Dose Sulfadoxine‐Pyrimethamine Intermittent Preventive Therapy for Malaria during Pregnancy among HIV‐Positive Zambian Women | Zendy

Christopher Gill | Zendy; William MacLeod | Zendy; Victor Mwanakasale | Zendy; Victor Chalwe | Zendy; Lawrence Mwananyanda | Zendy; Davies Champo | Zendy; Doreen Mukwamataba | Zendy; Roma Chilengi | Zendy; Donald M. Thea | Zendy; Davidson H. Hamer | Zendy

Open Access

Inferiority of Single‐Dose Sulfadoxine‐Pyrimethamine Intermittent Preventive Therapy for Malaria during Pregnancy among HIV‐Positive Zambian Women

Author(s) -

Christopher Gill,

William MacLeod,

Victor Mwanakasale,

Victor Chalwe,

Lawrence Mwananyanda,

Davies Champo,

Doreen Mukwamataba,

Roma Chilengi,

Donald M. Thea,

Davidson H. Hamer

Publication year - 2007

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/522137

Subject(s) - medicine , sulfadoxine , regimen , sulfadoxine/pyrimethamine , randomized controlled trial , pregnancy , parasitemia , malaria , low birth weight , population , obstetrics , pediatrics , pyrimethamine , immunology , environmental health , biology , plasmodium falciparum , genetics

The World Health Organization advocates 2-3 doses of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria (SP IPTp). The optimal number of doses and the consequences of single-dose therapy remain unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research